Meeting
2020 ASCO Virtual Scientific Program
Diagnostic performance of skeletal survey versus 18F-FDG-PET/CT for detecting lytic lesions in smoldering multiple myeloma.
Authors
Elizabeth M. Hill
NCI/NHLBI, Bethesda, MD
Elizabeth M. Hill , Alexander Dew , Candis Morrison , Peter L. Choyke , Esther Mena , Liza Lindenberg , Dickran Garo Kazandjian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 38: 2020 (suppl; abstr 8532)
DOI
10.1200/JCO.2020.38.15_suppl.8532
Abstract #
8532
Poster Bd #
432
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Focal bone marrow processes and early bone lesions in patients with multiple myeloma (MM) precursor diseases: A prospective study using molecular imaging.
First Author: Manisha Bhutani
Poster
2024 ASCO Annual Meeting
From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.
First Author: Mengmeng Ji
Poster
2024 ASCO Annual Meeting
Cost-effectiveness of a circulating tumor fraction molecular biomarker for treatment response monitoring.
First Author: Zachary Rivers
Poster
2023 ASCO Quality Care Symposium
Frequency of anti-resorptive therapy prescription and skeletal disease screening in patients diagnosed with multiple myeloma.
First Author: Amman Bhasin